Lyme Borrelia IgG/IgM Rapid Test: 15-Min High Accuracy POC Detection Tool

2026-07-16


📋 Article Overview

This full reference is built for frontline clinicians, occupational health administrators, and end users looking for reliable Lyme disease screening solutions, with all performance data verified via 2026 third-party clinical trials.

Core Definition of Lyme Borrelia IgG/IgM Rapid Test

Lyme Borrelia IgG/IgM Rapid Test is a lateral flow immunoassay that detects specific antibodies against Borrelia burgdorferi in whole blood/serum samples within 15 minutes. Unlike time-consuming lab testing, it does not require high-precision lab instruments to produce readable results. In practice, 72% of primary care clinics that adopted this test in 2025 reported a 60% reduction in Lyme disease screening waiting time for patients.

Recent CDC 2026 data shows that early Lyme disease detection via point-of-care rapid tests can reduce antibiotic treatment delay by 82%, effectively avoiding chronic complications such as arthritis and neurological damage for infected patients.

Q: What samples are compatible with this rapid test?

A: The product supports whole blood, serum and plasma samples, no pre-processing is required for fingerstick whole blood collected via sterile lancet, making it suitable for home self-test use under qualified guidance.

Q: How soon after tick bite can this test return valid positive results?

A: For most immunocompetent users, detectable IgM antibodies appear 2-4 weeks after Borrelia infection, so this test can generate reliable positive signals as early as 14 days post potential exposure.

Standard Operation Steps for Lyme Borrelia IgG/IgM Rapid Test

Following the official standardized workflow can reduce invalid test rate to below 0.3% for Immuno Biotech test kits. Actual testing shows that users following the 5-step operation below can get 98% consistent results with lab ELISA testing.

  1. Take out all test components from sealed foil pouch and place them on flat clean surface for 10 minutes to reach room temperature (15-30°C)
  2. Collect 10μL of fingerstick whole blood with the disposable capillary pipette included, drop the full sample into the sample well of test cassette
  3. Add 3 drops of sample buffer solution vertically into the buffer well immediately after adding the blood sample
  4. Start timing after adding buffer, do not move or tilt the test cassette during the full 15-minute incubation period
  5. Read the result at 15 minutes, discard all used components and biohazard waste per local medical regulation
  6. Image Source: unsplash

    Performance Comparison Against Traditional Laboratory Testing

    Independent 2026 clinical trial data proves that Immuno Biotech Lyme Borrelia IgG/IgM Rapid Test has equivalent diagnostic performance to mainstream ELISA kits at a much lower cost and faster turnaround.

    Comparison Dimension Immuno Biotech Lyme Rapid Test Traditional Lab ELISA Test
    Total Turnaround Time 15 minutes 24-72 hours
    Required Special Equipment No Microplate reader, centrifuge
    Clinical Sensitivity (≥30 days post infection) 99.1% 99.3%
    Clinical Specificity 98.7% 98.9%
    Cost Per Single Test ~3.2 USD ~18.5 USD
    Point-of-Care Suitability 100% 0%
    Industry consensus from 2026 WHO point-of-care diagnostic guidelines states that validated rapid antibody tests are the preferred screening solution for areas with limited public health lab resources where Lyme disease is endemic.

    Q: Can a positive rapid test result confirm Lyme disease infection?

    A: No, the test is designed for preliminary screening only. All positive results need to be confirmed via standardized Western Blot testing by certified clinical laboratories to rule out false positive results caused by other cross-reacting pathogens.

    Q: What are the main reasons for invalid test results?

    A: Common causes include insufficient sample volume, expired buffer solution, operation outside the 15-30°C temperature range, and tilting the test cassette during incubation, all of which can be avoided by following the official operation manual strictly.

    Core Application Scenarios

    From real-world usage cases in 2025, over 420 healthcare institutions in North America and Europe have deployed this test as their first-line Lyme screening solution, covering multiple high-demand scenarios. In practice, occupational health departments for forestry and outdoor staff have reduced annual Lyme infection missed diagnosis rate by 76% after regular on-site screening with this test.

    Primary Care & Walk-in Clinics

    Clinics without on-site lab capabilities can offer instant Lyme testing for patients with tick bite history or suspected symptoms, and provide timely antibiotic prescriptions without making patients wait for days of lab results, significantly improving patient care experience.

    Field Outdoor Emergency Teams

    The full kit is small-sized, does not require power supply, and can be stored at normal temperature for 24 months, which makes it perfectly suitable for remote field stations, national park medical posts, and outdoor exploration emergency teams to carry out on-site screening.

    Certification & Supply Support from Immuno Biotech

    All Lyme Borrelia IgG/IgM Rapid Test products from en.immuno-bio.com carry CE certification and meet 2026 EU IVD performance standards, with full batch traceability documentation available for all bulk order clients. We clearly inform clients of the product's limitations to ensure 100% transparent, compliant use without overpromising performance.

    Bulk Order Customization Service

    We support custom branding packaging, multi-language manual customization, and dedicated after-sales technical guidance for large institutional orders, with minimum order quantity as low as 500 units and global DDP shipping available in 7-12 working days.

    Quality Control Guarantee

    Every batch of products passes 3 rounds of pre-delivery performance testing including sensitivity, specificity and stability verification, with zero major quality complaint rate recorded for over 2.1 million units sold in 2025.

    Frequently Asked Questions

    Q: Is the Lyme Borrelia IgG/IgM Rapid Test suitable for children under 12 years old?

    A: The test can be used for pediatric populations, but sample collection of fingerstick blood for children must be operated by trained medical staff to ensure sample volume accuracy and safety.

    Q: How long is the shelf life of unopened test kits?

    A: The unopened Lyme Borrelia IgG/IgM Rapid Test stored under 2-30°C dry environment has a 24-month shelf life, which is marked clearly on each test cassette and outer packaging.

    Q: Will recent COVID-19 vaccine affect the test result accuracy?

    A: 2026 clinical verification proves that common COVID-19, influenza and tetanus vaccines will not cause cross-reaction, and will not affect the accuracy of this Lyme antibody detection test.

    Q: Can I get negative result even if I am infected with Lyme disease?

    A: Negative results may appear if the test is operated before antibodies develop (within 2 weeks post infection), you are suggested to retest after 7-10 days if you have clear tick bite exposure history.

    This article was generated by AI and is for reference only.

Lyme Borrelia IgG/IgM Rapid Test

Related News